Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| rF1V-1018 | UNITED THERAPEUTICS Corp (UTHR) |
Deep-dive into Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis